Navigation Links
ActivBiotics' Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
Date:4/2/2008

WELLESLEY HILLS, Mass., April 2, 2008 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced today the completion of the sale of ActivBiotics intellectual property assets for $3.5 million. The assets consisted of 1) Rifalazil, a Phase II antibiotic, 2) a library of novel rifamycin compounds, and 3) a clinical stage superoxide dismutase mimetic (SODm) and a library of SODm small molecules.

Mr. Finn praised the team of ActivBiotics executives who worked closely with him after the assets were assigned to him. He singled out Christo Shalish, MBA, Director of Business Development, Chris Murphy, Ph.D., Director of Pharmacology, and David Rothstein, Ph.D., Senior Director of Preclinical Development.

The sale of the assets was conducted through an Assignment for the Benefit of Creditors. This process entails transference of the assets to a fiduciary who then liquidates them for the benefit of the creditors of the company.

Source and Contact Information

Joseph F. Finn, Jr., CPA, Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481. E-mail: jffinnjr@earthlink.net, phone: 781-237-8840.


'/>"/>
SOURCE Finn, Warnke & Gayton
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer
2. ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008
3. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
4. ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates
5. Amarin Secures Global Intellectual Property Rights for Lipid Programs
6. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
7. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
8. NIST develops test method for key micromechanical property
9. New property found in ancient mineral lodestone
10. OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNAs, Including Its Phase III Compound Bevasiranib
11. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished life sciences ... , Avomeen is a leader in a wide range of services related ...
(Date:3/27/2017)... Linda, Ca (PRWEB) , ... March 27, 2017 ... ... metastatic colorectal cancer (mCRC) generally produce small, heterogeneous samples with limited tumor content ... analytical challenges remain to be resolved, such as the need for reliable detection ...
(Date:3/27/2017)... -- The new research portal will give visitors ... on Valero Energy , offering extensive market research on ... ... http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend gaining momentum ... today, even though touted as a green alternative to fossil ...
(Date:3/27/2017)... 27, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it is now ... for U.S. consumers who want to have their DarioHealth ... signed strategic alliance agreements with partners across the U.S. ... and if approved, will supply and bill the customer,s ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
Breaking Biology News(10 mins):